fbpx

SightRisk AMD Assessment Tool Makes North American Debut at VEW

SightRisk, a cloud-based AMD risk assessment tool, will launch to North America ECPs at Vision Expo West in Las Vegas on September 17, 2015. The service will be distributed in the Canada by MacuHealth, LLC via Bright Optical of Toronto.

SightRisk was developed by a team of research scientists who assessed both modifiable and non-modifiable risk factors of thousands of patients who were diagnosed with AMD through a detailed review of 300 published scientific manuscripts. The SightRisk questionnaire compiles and weighs based on the patient’s answers, creating a unique report that the ECP can review with their patients.

This report identifies young and healthy patients with risk profiles and helps the ECP make recommendations that may delay or prevent the onset of blindness from AMD later in life.

“It is important to take preventative action” said Frederic Jouhet, Managing Director of SightRisk. “Modifiable lifestyle factors such as smoking and a poor nutritional diet have been scientifically and clinically shown to increase the risk of developing AMD. Educating patients and continued monitoring of patient choices as early in life as possible will help reduce these risks.”

More information: http://www.sightriskusa.com/

Featured Posts

Voila Optik March-April 2024 lool Altair

Lool Eyewear Introduces New Collection for Deco Series

lool eyewear launches its SS24 collection, from the Deco Series. Inspired by art deco from minimalism, this collection expresses itself in noble metal finishes.

Learn More

Essilor Stellest Lenses Now Available in Sun Tints and an Extended Range

Essilor® Stellest™ lenses slow down myopia progression by 67% on average, compared to single vision lenses, when worn 12 hours a day.

Read more

WCO and CooperVision Partner on Myopia Management Navigator Educational Resource

Interactive Guide Aimed at Boosting Adoption of Myopia Management Global Standard of Care

Read more
contact lens institute

New Research Report Highlights Actions to Attract Potential & Former Contact Lens Patients

Contact Lens Institute™ Data Illustrates Significant Upside Opportunity for Eye Care Practices and Pinpoints What Drives Consideration

Read more

EssilorLuxottica to Release New Research Findings at ARVO, Including Five-year Clinical Findings of Essilor Stellest Lenses

EssilorLuxottica is taking part in the 2024 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Seattle, USA, where it will present new findings from its studies on advancements in myopia management with Essilor Stellest lenses..

Read more
Voila Optik March-April 2024 lool Altair

Lool Eyewear Introduces New Collection for Deco Series

lool eyewear launches its SS24 collection, from the Deco Series. Inspired by art deco from minimalism, this collection expresses itself in noble metal finishes.

Learn More

Essilor Stellest Lenses Now Available in Sun Tints and an Extended Range

Essilor® Stellest™ lenses slow down myopia progression by 67% on average, compared to single vision lenses, when worn 12 hours a day.

Read More

WCO and CooperVision Partner on Myopia Management Navigator Educational Resource

Interactive Guide Aimed at Boosting Adoption of Myopia Management Global Standard of Care

Read More
contact lens institute

New Research Report Highlights Actions to Attract Potential & Former Contact Lens Patients

Contact Lens Institute™ Data Illustrates Significant Upside Opportunity for Eye Care Practices and Pinpoints What Drives Consideration

Read More

EssilorLuxottica to Release New Research Findings at ARVO, Including Five-year Clinical Findings of Essilor Stellest Lenses

EssilorLuxottica is taking part in the 2024 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Seattle, USA, where it will present new findings from its studies on advancements in myopia management with Essilor Stellest lenses..

Read More
Voila Optik March-April 2024 lool Altair

Lool Eyewear Introduces New Collection for Deco Series

lool eyewear launches its SS24 collection, from the Deco Series. Inspired by art deco from minimalism, this collection expresses itself in noble metal finishes.

Learn More

Essilor Stellest Lenses Now Available in Sun Tints and an Extended Range

Essilor® Stellest™ lenses slow down myopia progression by 67% on average, compared to single vision lenses, when worn 12 hours a day.

Read more

WCO and CooperVision Partner on Myopia Management Navigator Educational Resource

Interactive Guide Aimed at Boosting Adoption of Myopia Management Global Standard of Care

Read more
contact lens institute

New Research Report Highlights Actions to Attract Potential & Former Contact Lens Patients

Contact Lens Institute™ Data Illustrates Significant Upside Opportunity for Eye Care Practices and Pinpoints What Drives Consideration

Read more

EssilorLuxottica to Release New Research Findings at ARVO, Including Five-year Clinical Findings of Essilor Stellest Lenses

EssilorLuxottica is taking part in the 2024 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Seattle, USA, where it will present new findings from its studies on advancements in myopia management with Essilor Stellest lenses..

Read more
Voila Optik March-April 2024 lool Altair

Lool Eyewear Introduces New Collection for Deco Series

lool eyewear launches its SS24 collection, from the Deco Series. Inspired by art deco from minimalism, this collection expresses itself in noble metal finishes.

Learn More

Essilor Stellest Lenses Now Available in Sun Tints and an Extended Range

Essilor® Stellest™ lenses slow down myopia progression by 67% on average, compared to single vision lenses, when worn 12 hours a day.

Read more

WCO and CooperVision Partner on Myopia Management Navigator Educational Resource

Interactive Guide Aimed at Boosting Adoption of Myopia Management Global Standard of Care

Read more
contact lens institute

New Research Report Highlights Actions to Attract Potential & Former Contact Lens Patients

Contact Lens Institute™ Data Illustrates Significant Upside Opportunity for Eye Care Practices and Pinpoints What Drives Consideration

Read more

EssilorLuxottica to Release New Research Findings at ARVO, Including Five-year Clinical Findings of Essilor Stellest Lenses

EssilorLuxottica is taking part in the 2024 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Seattle, USA, where it will present new findings from its studies on advancements in myopia management with Essilor Stellest lenses..

Read more